Recursion Pharmaceuticals
clinical non oncology orphan indication product prevalence is an under appreciated disease | Recursion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
January 2023
Slide
85 of 143
Related slides by other companies
Adagio Therapeutics
Investor Presentation
June 2023
| Adagio Therapeutics
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights